These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21957592)

  • 1. [Biological age and the pain syndrome at diabetic polyneuropathy].
    Galkin VV; Nesterova MV; Emel'ianov VV
    Adv Gerontol; 2011; 24(2):303-7. PubMed ID: 21957592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
    Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
    Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
    Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
    J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.
    Scheinfeld N
    Dermatol Online J; 2013 Nov; 19(11):20616. PubMed ID: 24314785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of convalis in the treatment of pain diabetic polyneuropathy and it's influence on biological age].
    Galkin VV; Nesterova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(1):97-100. PubMed ID: 22678685
    [No Abstract]   [Full Text] [Related]  

  • 6. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
    Terneus W
    J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Career lifetime advances and key developments: diabetes.
    Baglioni P; Govindan J; Khan A
    Clin Med (Lond); 2007 Jun; 7(3):303-4. PubMed ID: 17639617
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient compliance with SSRIs and gabapentin in painful diabetic neuropathy.
    Giannopoulos S; Kosmidou M; Sarmas I; Markoula S; Pelidou SH; Lagos G; Kyritsis AP
    Clin J Pain; 2007; 23(3):267-9. PubMed ID: 17314587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetic neuropathic pain with gabapentin alone or combined with vitamin B complex. preliminary results.
    Medina-Santillán R; Morales-Franco G; Espinoza-Raya J; Granados-Soto V; Reyes-García G
    Proc West Pharmacol Soc; 2004; 47():109-12. PubMed ID: 15633627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Symptomatic treatment of painful diabetic neuropathy].
    Maeda K; Yasuda H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():609-13. PubMed ID: 15999779
    [No Abstract]   [Full Text] [Related]  

  • 11. Gabapentin in treatment of restless legs syndrome in peritoneal dialysis patients.
    Tan J; Derwa A; Sanu V; Rahman N; Woodrow G
    Perit Dial Int; 2006; 26(2):276-8. PubMed ID: 16623436
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical inquiry: what medications are best for diabetic neuropathic pain?
    Page N; Deluca J; Crowell K
    J Fam Pract; 2012 Nov; 61(11):691-3. PubMed ID: 23256101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
    Beard SM; McCrink L; Le TK; Garcia-Cebrian A; Monz B; Malik RA
    Curr Med Res Opin; 2008 Feb; 24(2):385-99. PubMed ID: 18157921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
    Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
    J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplicative interactions to enhance gabapentin to treat neuropathic pain.
    Hayashida K; Eisenach JC
    Eur J Pharmacol; 2008 Nov; 598(1-3):21-6. PubMed ID: 18822281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duloxetine, a new therapeutic option for diabetic peripheral neuropathic pain].
    Ziegler D
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S284-8. PubMed ID: 17139588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of action of therapeutic agents in the treatment of chronic pain in the spinal cord].
    Kohno T; Obata H
    Masui; 2011 Nov; 60 Suppl():S113-20. PubMed ID: 22458029
    [No Abstract]   [Full Text] [Related]  

  • 18. Gabapentin therapy for diabetic neuropathic pain.
    Pérez HE; Sánchez GF
    Am J Med; 2000 Jun; 108(8):689. PubMed ID: 10896633
    [No Abstract]   [Full Text] [Related]  

  • 19. Gabapentin can improve dystonia in confirmed Wilson disease.
    Lerose M; Di Fabio R; Serrao M; Loudianos G; Pierelli F; Casali C
    Can J Neurol Sci; 2014 Mar; 41(2):284-5. PubMed ID: 24534048
    [No Abstract]   [Full Text] [Related]  

  • 20. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
    O'Connor AB; Noyes K; Holloway RG
    Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.